|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2003-10-13
|
|
pubmed:abstractText |
To evaluate serum levels of HER2 (an epithelial growth factor) and YKL-40 (a growth factor participating in inflammation and remodeling of the extracellular matrix) in relation to outcome in patients with their first diagnosis of recurrent breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adipokines,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/CHI3L1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lectins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4423-34
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:14555515-Adipokines,
pubmed-meshheading:14555515-Adult,
pubmed-meshheading:14555515-Aged,
pubmed-meshheading:14555515-Autoantigens,
pubmed-meshheading:14555515-Breast Neoplasms,
pubmed-meshheading:14555515-Female,
pubmed-meshheading:14555515-Glycoproteins,
pubmed-meshheading:14555515-Humans,
pubmed-meshheading:14555515-Lectins,
pubmed-meshheading:14555515-Lymphatic Metastasis,
pubmed-meshheading:14555515-Middle Aged,
pubmed-meshheading:14555515-Neoplasm Recurrence, Local,
pubmed-meshheading:14555515-Prognosis,
pubmed-meshheading:14555515-Prospective Studies,
pubmed-meshheading:14555515-Receptor, erbB-2,
pubmed-meshheading:14555515-Receptors, Estrogen,
pubmed-meshheading:14555515-Survival Rate,
pubmed-meshheading:14555515-Tumor Markers, Biological
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
|
|
pubmed:affiliation |
Department of Oncology, Herlev Hospital, Hvidovre Hospital, University of Copenhagen, DK-2750 Herlev Denmark. BVittrup@Dadlnet.dk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
